Aimmune Therapeutics (AIMT) Reports Licensing of Exclusive Worldwide Rights to Xencor (XNCR) XmAb7195 for Development of Next-Generation Food Allergy Treatments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. QCOM
6. ACN
7. AZN
8. ROIV
9. AAPL
10. HOOD

Go back to Aimmune Therapeutics (AIMT) Reports Licensing of Exclusive Worldwide Rights to Xencor (XNCR) XmAb7195 for Development of Next-Generation Food Allergy Treatments
AIMSI Technologies (NASDAQ: AIMT) Delayed: 34.49 --0 (-0%)
Previous Close $34.49    52 Week High $27.31 
Open $7.76    52 Week Low $9.77 
Day High $34.49    P/E N/A 
Day Low $34.49    EPS $0.00 
Volume 42,896       

XENCOR (NASDAQ: XNCR) Delayed: 25.33 -1.28 (4.81%)
Previous Close $26.61    52 Week High $26.50 
Open $26.09    52 Week Low $9.89 
Day High $26.49    P/E N/A 
Day Low $24.93    EPS $-0.51 
Volume 1,237,758